APA (7th ed.) Citation

Shivapurkar, N., Gay, M. D., He, A., Chen, W., Golnazar, S., Cao, H., . . . Smith, J. P. (2023). Treatment with a Cholecystokinin Receptor Antagonist, Proglumide, Improves Efficacy of Immune Checkpoint Antibodies in Hepatocellular Carcinoma. International journal of molecular sciences, 24(4), 3625. https://doi.org/10.3390/ijms24043625

Chicago Style (17th ed.) Citation

Shivapurkar, Narayan, et al. "Treatment with a Cholecystokinin Receptor Antagonist, Proglumide, Improves Efficacy of Immune Checkpoint Antibodies in Hepatocellular Carcinoma." International Journal of Molecular Sciences 24, no. 4 (2023): 3625. https://doi.org/10.3390/ijms24043625.

MLA (9th ed.) Citation

Shivapurkar, Narayan, et al. "Treatment with a Cholecystokinin Receptor Antagonist, Proglumide, Improves Efficacy of Immune Checkpoint Antibodies in Hepatocellular Carcinoma." International Journal of Molecular Sciences, vol. 24, no. 4, 2023, p. 3625, https://doi.org/10.3390/ijms24043625.